Related Experiment Video
Updated: May 29, 2025

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Phospho-TRIM21 orchestrates RPA2 ubiquitination switch to promote homologous recombination and tumor
Jie Zhang1,2, Bin Chen3, Feng Xu1,2
1High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Chinese Academy of Sciences, Anhui Province Key Laboratory of Environmental Toxicology and Pollution Control Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, China.
Abstract:
RPA2, a key component of the RPA complex, is essential for single-stranded DNA (ssDNA) binding and DNA repair. However, the regulation of RPA2-ssDNA interaction and the recruitment of repair proteins following DNA damage remain incompletely understood. Our study uncovers a novel mechanism by which phosphorylated TRIM21 (Phospho-TRIM21) regulates RPA2 ubiquitination, thereby modulating homologous recombination and tumor radio/chemo-resistance. In the absence of DNA damage, TRIM21 mediates K63-linked ubiquitination of RPA2, countering K6-linked ubiquitination. Upon DNA damage, ubiquitination-modified RPA2 binds ssDNA, stabilizing the DNA structure and facilitating ATRIP/ATR recruitment. ATR subsequently phosphorylates TRIM21 at Ser41, leading to the dissociation of the TRIM21-RPA2 complex and a shift in RPA2 ubiquitination from K63 to K6 linkage. This shift maintains RPA2 ubiquitination homeostasis and stabilizes the RPA2-ATRIP complex, which is crucial for efficient homologous recombination (HR) repair and enhanced tumor radio/chemo-resistance. We also demonstrate that TRIM21 is frequently upregulated in cancers, and its depletion sensitizes cancer cells to radio/chemotherapy, suggesting its potential as a therapeutic target. This study provides novel insights into TRIM21's role in the DNA damage response and its implications for cancer treatment.
Insights
Phosphorylated TRIM21 regulates RPA2 ubiquitination, impacting DNA repair and tumor resistance. This mechanism is crucial for homologous recombination and cancer therapy.
Area of Science:
- Molecular Biology
- DNA Repair Mechanisms
- Cancer Biology
Background:
- Replication protein A (RPA) complex, particularly RPA2, is vital for DNA repair.
- Regulation of RPA2-ssDNA interactions and repair protein recruitment post-DNA damage is not fully understood.
Purpose of the Study:
- To elucidate the novel mechanism of TRIM21 in regulating RPA2 ubiquitination.
- To understand the role of this regulation in homologous recombination and tumor radio/chemo-resistance.
Main Methods:
- Investigated TRIM21's role in RPA2 ubiquitination.
- Analyzed the impact of TRIM21 phosphorylation on RPA2 ubiquitination status.
- Studied the recruitment of ATRIP/ATR and its relation to RPA2 ubiquitination.
- Assessed the effect of TRIM21 depletion on cancer cell sensitivity to radio/chemotherapy.
Main Results:
- TRIM21 mediates K63-linked ubiquitination of RPA2 in undamaged cells.
- Upon DNA damage, ATR phosphorylates TRIM21, causing a shift to K6-linked ubiquitination of RPA2.
- This ubiquitination shift stabilizes the RPA2-ATRIP complex, promoting homologous recombination (HR) repair.
- TRIM21 upregulation in cancers correlates with radio/chemo-resistance; its depletion sensitizes cancer cells.
Conclusions:
- Phosphorylated TRIM21 is a key regulator of RPA2 ubiquitination in the DNA damage response.
- This regulatory pathway is critical for homologous recombination repair and tumor resistance to therapy.
- TRIM21 represents a potential therapeutic target for enhancing cancer treatment efficacy.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Restarting Stalled Replication Forks
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...

